Summary. The virulence (expressed as LD50 values) for mice of two mutant strains of Salmonella dublin, both containing TnA insertions in the resident plasmid, was reduced by 104-105 when infection was by the oral or intravenous or intraperitoneal route. When the plasmid was lost from one of the mutants no further decrease in virulence was observed. Results also suggested that plasmid genes are not involved in the ability of S. dublin to cross the gut wall.
Introduction
Plasmids play a role in the pathogenicity of Salmonella typhimurium (Jones et al., 1982) and S. dublin (Terakado et al., 1983) . Jones and his colleagues also showed that a plasmid in S. typhimurium was essential for adhesion to, and invasion of, HeLa cells (Jones et al., 1982) . The role in pathogenicity of the S. dublin plasmid has not been identified.
This paper describes two mutant strains of S. dublin which have substantially lost virulence through a single transposon insertion in the resident plasmid (mol. wt 46 x lo6). The derivation of these strains from the wild type and the plasmid DNA of the wild-type and mutant strains are described in detail by Baird and Manning (1984) . In this study, a comparison has been made of the behaviour of the parent and mutant strains in virulence experiments in mice in the hope of identifying the role of the plasmid in pathogenicity. Some results have been published in preliminary form .
Materials and methods

Bacterial strains.
S. dublin strain 2229 was smooth, aerogenic and virulent for mice and calves. It was isolated from an outbreak of calf enteritis in Britain in 1979. The mutants also used in this study (strains M51 and M173) were transposon-insertion mutants of strain 2229. In each there was a single insertion of transposon TnA in the serotype-specific plasmid (rnol. wt 46 x lo6); in the case of strain M51, the transposition event resulted in the deletion of a segment of DNA of c. 3 kilobase-pairs . Strain 173/2 was a cured derivative of mutant MI73 without the 46 x 106-moI. wt plasmid (see below). Escherichia coli K 12 strain 14R525, a plasmid-free, serum-sensitive laboratory strain was kindly supplied by Dr H. R. Smith (P.H.L.S., Colindale, London).
Curing of plasmid DNA
Mutant M 173, whose plasmid contained TnA encoding ampicillin resistance, was grown overnight in LuriaBertani (LB) broth containing the curing agent ethidium bromide 10 pg/ml. To enrich for ampicillin sensitivity (indicating possible loss of the plasmid) the method of Rodriguez et al. (1976) was adopted. One ml of the overnight broth culture was subcultured into 100 ml of fresh LB broth and incubated at 37°C for 1 h. Ampicillin was added to a final concentration of 500 pg/ml, and the culture incubated at 37°C for a further 45 min. Cycloserine, which in this situation kills only actively growing, ampicillin-resistant bacteria, was then added to a final concentration of 100 pg/ml. After incubation at 37°C for another 2.5 h, 100-pl portions of undiluted culture and of a 1 in 10 dilution were spread on LB agar plates which were incubated overnight at 37°C. Each plate was then replica-plated on to LB agar plates containing ampicillin 500 pg/ml and ampicillin-sensitive colonies were sought. Only one ampicillin-sensitive (Amps) derivative was identified in a total of c. 25000 colonies examined. This derivative, designated 173/2, was serologically and biochemically identical to S. dublin strain M173. Plasmid analysis (see below) showed that it lacked the plasmid of mol. wt 46 x lo6.
Viable counts
Bacterial counts were determined in inocula and in other samples by making serial ten-fold dilutions of the samples in saline and spreading 0.1 ml of appropriate dilutions on LB agar plates. The number of cfu/ml or /g was calculated.
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Virulence testing
The virulence of each bacterial strain was tested in C57 BL/COM mice, except in two experiments in which Lac/ G/COM mice were used. Strains were grown in LB broth at 37'C for 16 h. Dilutions were made in saline and administered orally to groups of eight mice (0.1 ml/ mouse). Deaths were monitored up to 14 days and LD50 values calculated by the method of Reed and Muench (1938) . The number of organisms administered to each animal was calculated from viable counts of the inocula. In some experiments the challenge doses were injected into the mice by the intraperitoneal (ip) or intravenous (iv) (tail vein) route (0.1 ml/mouse).
Counts of bacteria in spleens
The appropriate dilution (determined from preliminary experiments) of an overnight broth culture of each test strain was given by mouth to groups of C57BL/COM mice (0.1 ml/mouse). At various times after administration, spleens, usually from groups of four mice, were removed, pooled and weighed. Saline (9 ml/g of tissue) was added and samples were homogenised in Griffith's tubes. Appropriate dilutions of the homogenates were spread on LB agar plates for the determination of viable counts.
Plasmid analysis
Plasmids were extracted by the method of Birnboim and Doly (1979) , and analysed by electrophoresis in 0.6% agarose gels run horizontally at 100 V for 5 h, in a Trisacetate buffer system (Tris 4.48 g, sodium acetate 0.68 g, EDTA 1.49 g, in 1 L, pH 7.8). Plasmid bands were visualised by immersing the gel in ethidium bromide 50 pg/ml for 1-16 h.
Serum resistance determination
Serum resistance was assayed by the method of Taylor et al. (1972) . Overnight broth cultures of each test organism were subcultured into fresh LB broth (0.5 ml into 10ml) and grown to an ODsso of 0.5. A ten-fold dilution was then made to give a concentration of c. 2 x 1 O7 bacterialml, and 0.5-ml portions of this suspension were added to various dilutions (in saline) of rabbit or bovine serum, to give a final assay volume of 2.5 ml. Samples were incubated at 37°C for 90 min. Appropriate dilutions of each sample were prepared and viable counts determined at times 0 and 90 min.
Haemagglu t in in assays
Mannose-resistant and mannose-sensitive haemagglutinins were assayed by the microhaemagglutination method of Jones and Rutter (1974) .
Results
LD.50 values after oral administration
The oral LD50 value of strain 2229 was 104-105 less than that of strains M 173 (table I; see also Baird and Manning, 1984) and M51 (table I). The virulence of the cured derivative (173/2) of strain M 173 ( fig. 1 ) was low in mice, similar to that of strain M173 itself (table I).
Invasiveness of wild-type and mutant strains
The invasiveness of the S. dublin strains, expressed as the ability of the bacteria to cross the gut wall and accumulate in various tissues after oral administration, was assessed because several recent reports have described virulence plasmids that confer invasive properties upon S. typhimurium (Jones et al., 1982) and Shigella spp. (Hale et a/., 1983) . For a given dose, the accumulation of strain M5 1 inspleen waslower than that ofthe parent strain 2229( fig. 2A ). After administrationofa lethal doseof strain 2229, counts in spleen tissue reached 1 0'-lo8 cfu/spleen by the time of death (day 4) ( fig. 2A) . After a dose of c. 1 LD50 of strain M51, bacteria accumulated to high counts in the spleen by day 7, but then counts dropped substantially ( fig. 2B ). This can probably be explained by the fact that each sample was a pool of four spleens and approximately half of the animals given this dose would be expected to die, therefore each pooled sample (up to day 10) would contain two spleens from mice that would have died and two from mice that would have survived. However no mice died after day 10, therefore all spleens taken from day 10 onwards would have been from mice that survived the challenge, and would have lower bacterial counts in 
Haemagglutinin production
Adhesion to, and invasion of, HeLa cells by S . typhimurium depends upon a mannose-resistant haemagglutinin (MRHA) (Jones and Richardson, 1981) . Therefore we assayed MRHA and also mannose-sensitive haemagglutinins (MSHA) in strain 2229, mutants M5 1 and M 173, and the cured derivative 173/2. MSHA was detected in each strain but MRHA was not, indicating that MRHA is not involved in the virulence of S. dublin strain 2229 and 
LD.50 values after ip or iv injection
To assess further the invasiveness of the mutants in mice, their virulence after ip and iv injection was determined. If the invasiveness of mutants M51 and M 173 had been altered by the transposon insertion, their virulence after ip or iv injection, which bypasses the gut invasion step of pathogenesis, should have been more like that of the parent strain.
However, there was still a 104-105 difference between the LD50 values of the wild-type and mutant strains (table I) . This suggests that the reduced virulence of the mutants for mice when administered by mouth was not due to reduced invasion of the gut.
Serum resistance
Measurements were made in oitro of the serum resistance of strain 2229, mutants M51 and M 173, and the cured derivative 173/2. All strains were equally resistant to rabbit serum; they grew in a final serum concentration of 80%. Each strain was slightly sensitive to bovine serum (table 2).
Discussion
Our virulence studies on S. dubfin wild-type and mutant strains have shown that the S. dublin plasmid of mol. wt 46x lo6 is important for the pathogenicity of the organism. These results are in agreement with those of other workers (Jones et al., 1982; Terakado et af., 1983) . However, the plasmid does not seem to affect the ability of the organism to cross the mouse gut wall, because loss of virulence in the mutants was unaffected by the route of inoculation. This contrasts with the role of the S . typhimurium plasmid in invasion of HeLa cells (Jones et al., 1982) . The virulence of the cured derivative 173/2 was similar to that of mutants M173 and M51, indicating that the residual virulence of this cured derivative (and probably also of M51 and M 173) is chromosomal1 y-encoded.
The ip and and iv routes of inoculation are highly efficient methods of establishing infection with S . dublin strain 2229 in mice. It was not possible to calculate an LD50 value for strain 2229 but a dose of c 5 cfu was always lethal (table 1). If only one or two organisms need to cross the gut wall to establish infection (Collins, 1972) , it is perhaps not surprising that we have been unable to correlate virulence with adhesion to, or invasion of, intestinal cells and membranes. Indeed, invasion of the gut may be a passive process and an "invasive" organism may simply be one that can survive host defence processes once it has penetrated the gut wall.
The finding that each S. dublin strain tested showed mannose-sensitive, but not mannose-resistant, haemagglutinating activity indicated that MSHA is not plasmid encoded, and that MRHA is not involved in the virulence of S. dubfin strain 2229 in mice. Tavendale et al. (1983) suggested that MSHA, and not MRHA, is necessary for the adhesion of S. typhimurium to HEp2 and HeLa cells in vitro. However, MSHA is not thought to be essential for infection (Duguid et al., 1976; Tavendale et al., 1983) , therefore adhesion to cells in vitro may not be a good model for virulence in vivo. Although MRHA was not detected in strain 2229, c. 60% of all other S. dublin strains tested had MRHA activity against at least one species of erythrocyte (G. T. H. Brown and E. J. Manning, unpublished results) . Thus strain 2229 differs in this respect from many other S . dublin isolates, and also from the S. typhimurium strains described by Jones and Richardson (1 98 1).
Because our results suggested that the mutants had not lost their ability to cross the gut wall, it seemed possible that their reduced virulence might be due to diminished ability to resist host defences. One aspect of resistance to host defences is the ability of certain bacteria to resist the bactericidal action of normal serum (Taylor and Hughes, 1978) but the wild-type and mutant strains were equally instances an insertion-mutation in the 46 x lo6-resistant to rabbit and to bovine serum. The serum mol. wt plasmid of S. dublin reduces virulence of the resistance of S. dublin strain 2229 must be chrorno-organism, but apparently not by affecting its ability somally encoded, unlike that of some E. coli strains to cross the gut wall. The possibility that the (Taylor and Hughes, 1978) 
